ABSTRACT
The idea behind biostructure-based drug design is to utilize the information on shape and properties of the binding site of a target molecule (e.g., enzyme or receptor) to design compounds, which possess complementary properties. Thus, biostructure-based drug design requires methods for determination of the three-dimensional (3D) structure of the target molecules as well as knowledge of which molecular interactions are important to obtain the desired binding characteristics.
